BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang N, Shi J, Shi X, Chen W, Liu J. Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:12797-809. [PMID: 33363385 DOI: 10.2147/OTT.S275688] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Liu Q, Zheng S, Liu T, Yang L, Han X, Lu X. Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation. J Cancer 2021;12:4830-40. [PMID: 34234853 DOI: 10.7150/jca.58494] [Reference Citation Analysis]
2 Luo C, Chen X, Bai Y, Xu L, Wang S, Yao L, Guo X, Wang D, Zhong X, Falzone L. Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma. International Journal of Genomics 2022;2022:1-27. [DOI: 10.1155/2022/9305081] [Reference Citation Analysis]
3 Luo JP, Wang J, Huang JH. CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci Rep 2021;41:BSR20211103. [PMID: 34405225 DOI: 10.1042/BSR20211103] [Reference Citation Analysis]
4 Lu M, Li J, Fan X, Xie F, Fan J, Xiong Y. Novel Immune-Related Ferroptosis Signature in Esophageal Cancer: An Informatics Exploration of Biological Processes Related to the TMEM161B-AS1/hsa-miR-27a-3p/GCH1 Regulatory Network. Front Genet 2022;13:829384. [DOI: 10.3389/fgene.2022.829384] [Reference Citation Analysis]
5 Feng A, Yang N, Yu R, Liu J, Pang J, Wu X, Shao Y, Yang Z, Dai H. Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy. Onco Targets Ther 2022;15:41-51. [PMID: 35046666 DOI: 10.2147/OTT.S334580] [Reference Citation Analysis]